Many clinical studies have shown that autopsies of patients with anti-IgLON5 antibody-associated neurological disorders reveal the deposition of phosphorylated Tau protein in certain regions of the midbrain, brainstem, and cerebellum. The gene discussed is MAPT; the disease is nervous system disorder.